What happens during a C&P exam for Ovarian Cancer?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Ovarian Cancer

Q: What are the VA rating percentages for Ovarian Cancer?

Ovarian Cancer (DC 7627) is rated at 100% under 38 CFR § 4.116, DC 7628. Per § 4.116 DC 7627, malignant neoplasms of the gynecological system are rated 100%. The 100% rating "shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined" by mandatory VA examination. If there has been no recurrence or metastasis, rate on residuals; rating changes are subject to § 3.105(e).

Q: What rates 100% for Ovarian Cancer under 38 CFR § 4.116, DC 7628?

Under 38 CFR § 4.116, DC 7628 (DC 7627), a 100% rating for Ovarian Cancer requires: Per § 4.116 DC 7627, malignant neoplasms of the gynecological system are rated 100%. The 100% rating "shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined" by mandatory VA examination. If there has been no recurrence or metastasis, rate on residuals; rating changes are subject to § 3.105(e).

Q: What evidence do I need for a Ovarian Cancer VA claim?

Key evidence for a Ovarian Cancer claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 762738 C.F.R. § 4.116

Diagnostic Code

DC 7627

38 C.F.R. § 4.116

Rating Range

100–100%

1 severity tier

Source

Verified

38 C.F.R. § 4.116

Ovarian Cancer is rated by the U.S. Department of Veterans Affairs under DC 7627 of 38 CFR § 4.116, DC 7628 across 1 severity tier (100%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Malignant neoplasm of the ovary. Often diagnosed at advanced stages. Rated 100% during active disease. Associated with Agent Orange exposure as a presumptive condition under the PACT Act.

Rating Criteria

100%

Per § 4.116 DC 7627, malignant neoplasms of the gynecological system are rated 100%. The 100% rating "shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined" by mandatory VA examination. If there has been no recurrence or metastasis, rate on residuals; rating changes are subject to § 3.105(e).

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.116 (Gynecological conditions and disorders of the breast). Source verified 2026-05-15 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.116 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING